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Background: Vitamin A deficiency can cause anemia as the nutrient is essential for hematopoiesis, mobilization of
iron store and immunity. Nevertheless, clinical trials endeavored to evaluate the effect of Vitamin A Supplementation
(VAS) on hemoglobin concluded inconsistently. Accordingly, the objective of the current study is to assess the effect of
single high dose VAS on the hemoglobin status of children aged 6–59 months.
Methods: The study was conducted based on the data of Ethiopian Demographic Health Survey 2011. The data from
2397 children aged 6–59 months who received a single dose of 30 or 60 mg of VAS (depending on age) in the
preceding 6 months were matched with similar number children who did not receive the supplement in the reference
period. The matching was based on propensity scores generated from potential confounders. Distributions of
hemoglobin concentration and risks of anemia were compared between the groups using paired t-test, matched
Relative Risk (RR) and standardized mean difference.
Result: The supplemented and non-supplemented groups were homogeneous in pertinent socio-demographic
variables. Compared to propensity score matched non-supplemented children, those who received vitamin A
had a 1.50 (95% CI: 0.30-2.70) g/l higher hemoglobin concentration (P = 0.014). In the supplemented and
non-supplemented groups, the prevalences of anemia were 46.4% and 53.9%, respectively. VAS was associated
with a 9% reduction in the risk of anemia (RR = 0.91 (95% CI: 0.86-0.96)). Stratified analysis based on household
wealth status indicated that the association between VAS and hemoglobin status was restricted to children from
the poor households (RR = 0.74 (95% CI: 0.61-0.90)). Effect size estimates among all children (Cohen’s d = 0.07)
and children from poor households (d = 2.0) were modest.
Conclusion: Single high dose VAS among Ethiopian children 6–59 months of age was associated with a modest
increase in hemoglobin and decrease in risk of anemia. Household wealth status may modify the apparent
association between VAS and hemoglobin status.
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Anemia is a global public health problem affecting both
developing and developed countries. It poses serious
consequences for human health including increased risk
of maternal and child mortality [1]. According to World
Health Organization (WHO), anemia affects 24.8% of
the world population and the burden is substantially
high among preschool-aged children (47.4%), pregnant
women (41.8%) and women of reproductive age (30.2%)
[1]. In 2002 Iron Deficiency Anemia (IDA) was identified
as one of the major contributing factors to the global
burden of disease [2].
Over years several studies documented the public health
significance of anemia in Ethiopia. The recent Ethiopia
Demographic and Health Survey (EDHS) 2011 reported
44.2%, 22.0% and 16.6% prevalence of anemia among
preschool-aged children, pregnant women and non-
pregnant women, respectively [3]. The previous EDHS
2005 also reported relatively higher (53.5%, 30.6% and
26.6%) prevalences in the aforementioned three popu-
lation groups, consecutively [4].
Several factors, both nutritional and non-nutritional,
are known to contribute to the onset of anemia. How-
ever, nutritional anemia is the most widespread type.
Especially IDA is estimated to contribute to approxi-
mately 50% of the global burden of anemia – though the
proportion may vary according to local situations. Other
micronutrient deficiencies including folate, vitamin B-12,
vitamin C, Vitamin A (VA), zinc and cooper are also
linked with anemia [1,5].
The relationship between Vitamin A Deficiency (VAD)
and anemia has been known for many decades now [6].
So far various pathophysiological mechanisms had been
postulated. Vitamin A appears to enhance hematopoiesis
and mobilization of iron store possibly through increas-
ing circulating erythropoietin [6,7]. VA could also pre-
vent anemia associated with infection via its immu
ne-modulatory effect [6]. Vitamin A deficiency might
also alter absorption and storage of iron [5].
Several observational studies witnessed significant associ-
ation between hemoglobin and various VA status indica-
tors [6]. Reasonable number of Randomized Controlled
Trials (RCTs) based on daily or weekly VA Supplementa-
tion (VAS) have also concluded likewise [8-12]. However,
RCTs based on single high dose VAS concluded equivo-
cally. Studies in Thailand [13], Indonesia [14] and Morocco
[7] reported positive effects; whereas, those in Peru [15]
and Thailand [16] found no association.
In settings where VAD is a public health problem, the
WHO recommends for routine and high dose VAS every
4–6 months for children 6–59 months [17]. This is based
on the knowledge that a single, large dose of VA is well
absorbed in the liver and can be mobilized over an
extended period of time as required. The recently revisedWHO guideline emphasizes on the significance of VAS
for the reduction of childhood mortality, xerophthalmia
and nutritional blindness [17]. The systematic review
by Cochrane collaboration also concluded that VAS re-
duces all-cause childhood mortality by 24% [18].
Accordingly the current study, based on the data of
EDHS 2011, was carried out in order to evaluate the effect
of routine high dose VAS on hemoglobin status of chil-
dren aged 6–59 months. The aforementioned dataset was
selected, considering the fact that the prevalences of VAD
and anemia are known to be high in Ethiopia [3,4,19] and
the country is also implementing large scale semi-annual
VAS for children aged 6–59 months.
Methods
Study design
The current study – a retrospective cohort by design – is
a secondary data analysis of the Ethiopia Demographic
and health survey (EDHS) carried out in 2011. Children
aged 6–59 months who received and did not receive VAS
in the preceding 6 months of the survey were identified
and matched using propensity score matching technique.
Ultimately mean hemoglobin concentration and anemia
status determined at the time of the survey were com-
pared between the two study groups.
Study setting
Ethiopia is among the least developing countries in the
world with Gross Domestic Product (GDP) per capita of
1,200 USD [20]. Of approximately 80 million Ethiopians,
84% live in rural areas where access to social services is
limited [21]. The country’s economy is dependent on
agriculture and 29.2% of the population lives below the
poverty-line [20]. Despite the recent improvements in
health indicators, infant and under five mortality rates
(50 and 88 deaths per 1,000 live births, respectively)
remain high and the life expectancy at birth does not
exceed 57 years [3,20]. Malnutrition remains a major
problem as 44%, 29% and 10% of the preschool-aged
children are stunted, underweight and wasted, respect-
ively [3]. Widespread poverty, food insecurity and lim-
ited access to social services have contributed to the
high burden of ill-health in the country [20].
Parallel to the recommendation of WHO, Ethiopia
implements routine VAS for children 6–59 months.
According to the national guideline, children aged 6–11
and 12–59 months are given 100,000 and 200,000 inter-
national units of VA (i.e. 30 and 60 mg of retinol), respect-
ively, on semi-annual basis [22]. Usually VA capsules are
distributed through Enhanced Outreach Strategy/Com-
munity Health Days (EOS/CHD) campaigns. Other ser-
vices provided during the campaign include deworming
of children 24–59 months and nutritional screening of
children 6–59 months. VAS is also conducted during
Figure 1 Flowchart of the study.
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tions. According to DHS 2011 the coverage of VAS in the
aforementioned age group in the country was 53.1%.
Sampling design
The EDHS 2011 applied two stage cluster sampling tech-
nique. Enumeration Area (EA) — a cluster that conven-
tionally encompasses 150–200 adjacent households — was
the first stage sampling unit. The original survey included
624 EAs, 187 in urban and 437 in rural areas. Ahead of
the survey, a complete listing of households was carried
out in each of the EAs and eventually 17,817 households
were randomly selected [3].
For the current analysis, the data of 9,276 children
aged 6–59 were available. However, for various reasons
the data of only 4,794 children were used for the ana-
lysis. Reasons for exclusion were; lack of information
about the VAS status or hemoglobin concentration of
the children, missing values for the variables needed to
generate propensity score and unable to find appropriate
matches (Figure 1). Children included and excluded from
the study were not significantly different in terms of basic
socio-demographic variables include age, sex, place of resi-
dence (urban/rural), wealth index and parents’ educational
status (P > 0.05).
Power calculation
Power to detect a difference in the prevalence of anemia
was computed based on the available number supple-
mented and non-supplemented children in the dataset
and the prevalences of anemia found in the two groups.
The computation was made using the online calculator
called StatsToDo which is designed for matched study
design [23]. The inputs of the calculation were: 95%
confidence level; 2,397 pairs of supplemented and non-
supplemented subjects; 46.7% and 53.9% prevalences of
anemia in supplemented and non-supplemented children;
and one-to-one ratio between the two study groups. Even-
tually the power was computed as 79.8% and it was judged
to be optimal.
Data collection
The EDHS 2011 data were collected from December
2010 to June 2011 using trained and experienced data
collectors. The survey used standard MEASURE DHS
questionnaire adapted to the Ethiopian context. The
questionnaire was finalized in English and translated to
three major local languages. Prior to the fieldwork, the
tools were pretested and all necessary modifications
were made [3].
Exposure and outcome ascertainments
During the survey VAS status of the children was deter-
mined by showing their mothers/primary caregivers aVA capsule and enquiring whether their children had
been given a similar one in the preceding 6 months [3].
Hemoglobin concentration was determined via portable
HemoCue analyzer using a drop of capillary blood and
the concentration was adjusted for altitude according
to the recommendation of Centers for Disease Preven-
tion and Control (CDC) [24]. The cutoff points applied
to define anemia were: mild (100–109 g/l), moderate
(70–99 g/l) and severe (< 70 g/l).
Matching of VA supplemented and non-supplemented
children
The propensity score is the conditional probability of
assignment to a particular treatment given a vector of
observed covariates [25]. Propensity score matching re-
fers to the pairing of treatment and control units with
similar values on the propensity score. It is an important
tool for causal inference in retrospective cohort and
quasi-experimental studies in which random assignment
of treatments is impossible and asymmetry of treatment
groups is likely. Propensity score matching avoids selec-
tion bias associated with covariates used to predict the
score [26].
In the current analysis propensity scores were generated
via binary logistic regression model that compute the
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eleven factors/covariates. The factors/covariates were
wealth index, parents’ educational status, place of resi-
dence (urban or rural), age of the child, sex of the child,
number of preschool age children in the household,
household’s usual source of drinking water (improved
or unimproved), household’s excreta disposal method
(improved or unimproved), vaccination status of the
child, and deworming treatment of the child within
6 months of the survey. Child illness related variables
were not considered in generating the propensity scores
as they are potential mediator factors between VAS and
hemoglobin status.
Eventually, every VA supplemented child was matched
with a non-supplemented one using a variant of pro-
pensity score matching method called Caliper matching
(i.e. matching to a control with the nearest propensity
score that is within a predefined width). The caliper
width was set as 0.2 of the Standard Deviation (SD) of
the logit of the propensity score [27]. Ultimately 2,397
VA supplemented and 2,397 non-supplemented chil-
dren were matched.
Data management and analysis
The dataset was downloaded from Measure DHS web-
site and cleaned using SPSS 20.0 software. The data
were subsequently exported to Stata SE 11 for analysis.
Mean hemoglobin concentrations in supplemented and
non-supplemented children were compared using paired
t-test. The association between VAS status and anemia
was determined via McNemar’s Chi-square and matched
Relative Risk (RR). Both were generated using the Stata
MCC command modified for matched cohort design [28].
Statistical significance was set at P value of 0.05. Effect
Size (ES) calculation was made using the standardized
mean difference method. Prior to analysis the assumptions
of McNemar’s Chi-square and t-tests had been checked.
In order to assess the effectiveness of the propensity
score matching, the comparability of the two treatment
groups on the variables used to generate the propensity
score was checked using paired t- or McNemar’s Chi-
square- tests. Further, the similarity of the groups based
on other selected variables including dietary diversity score,
meal frequency and breastfeeding was assessed. Dietary
diversity score was calculated according to the recommen-
dation of the WHO [29].
Wealth index was computed as a composite indicator
of living standard based on 18 variables related to own-
ership of selected household assets, size of agricultural
land, quantity of livestock and materials used for hous-
ing construction. The computation was made using
principal component analysis. Initially the analysis
generated six principal components and a single con-
tinuous variable was generated by summing up theprincipal components into one. Tertiles of wealth
index (poor, middle and rich) were generated using the
composite score.
Ethical consideration
The dataset was accessed after securing permission from
Measure DHS organization. During the survey, the data
were collected in confirmation of national and international
ethical guidelines. Ethical clearance for the survey was pro-
vided by the Ethiopian Health and Nutrition Research Insti-
tute (EHNRI) review board, the National Research Ethics
Review Committee (NRERC) at the Ministry of Science
and Technology, the Institutional Review Board of ICF
International, and the CDC [3].
Results
Background characteristics of the study subjects
A total of 2,397 pairs of VA supplemented and non-
supplemented children were included in the analysis. In
order to evaluate the overall effectiveness of the propensity
score matching, the basic characteristics of the two groups
were compared using paired t- or McNemar’s Chi-square-
tests. The mean (±SD) propensity score was virtually iden-
tical for the two groups (0.50 ± 0.17 for both).
The mean (±SD) age of the children in supplemented
and non-supplemented groups were 31.6 (±15.3) and
31.7 (±15.9) months (P = 0.718). The boys to girls ratios
were 1.03 and 1.02, consecutively, (P = 0.974). Likewise,
the study groups were comparable with respect to socio-
economic status indicators including parents’ educa-
tional status, place of residence, household wealth index
and household size (P > 0.05). Access to improved water
source and sanitary facility, proportion of children who
completed vaccination, and proportion of children who
received deworming tablets in the preceding 6 months
of the survey, were also similar. Further, among children
aged 6–23 months, proportion who were breastfeeding
during the survey and mean food frequency and dietary
diversity score in the preceding day of the study were
comparable (P > 0.05) (Table 1).
Vitamin A supplementation and anemia
The mean (±SD) hemoglobin levels in supplemented
and non-supplemented children were 107.5 (±17.9)
and 106.0 (±23.8) g/l, respectively, reflecting a signifi-
cant mean difference of 1.50 (95% CI: 0.30-2.70) g/l in
favor of the supplemented group (t = 2.471, P = 0.014)
(Table 2).
Amongst supplemented children, the prevalence of
anemia was 46.4% (95% CI: 44.4-48.4%). About 20.3%,
22.1% and 3.2% had mild, moderate and severe anemia,
respectively. Alternatively, among non-supplemented chil-
dren, the prevalence of any form of anemia was 53.9%
(95% CI: 51.9-55.9%) and 3.9%, 27.8% and 3.9% had mild,
Table 1 Comparison of the characteristics of vitamin A supplemented and non-supplemented children aged
6–59 months, Ethiopia, 2010
Variables VAS status Test statistic and






Mean child age in months (mean (±SD)) 31.6 (±15.3) 31.7 (±15.9) t = 0.36, P = 0.718
Proportion of female children (%) 49.4 49.4 χ2 = 0.00, P = 0.974
Proportion of mothers who had any formal education (%) 30.1 28.0 χ2 = 3.79, P = 0.056
Proportion of fathers who had any formal education (%) 47.0 46.6 χ2 = 0.08, P = 0.799
Proportion of urban residents (%) 14.0 14.5 χ2 = 0.29, P = 0.629
Mean wealth index score (mean (±SD)) −0.36 (±0.07) −0.36 (±0.07) t = 0.29, P = 0.770
Proportion of households with improved water source (%) 51.1 51.4 χ2 = 1.11, P = 0.317
Proportion of households with improved sanitary facility (%) 11.1 10.9 χ2 = 0.09, P = 0.806
Proportion of children who received deworming tablet within 6 months (%) 9.6 9.3 χ2 = 3.27, P = 0.119
Household size (mean (±SD)) 6.18 (±2.32) 6.18 (±2.33) t = 0.06, P = 0.995
Proportion of children 12–59 months who completed vaccination (%)♦ 64.2 64.5 χ2 = 1.26, P = 0.337
Proportion of children 6–23 months who were breastfeeding during the survey* 91.7 89.7 χ2 = 0.47, P = 0.492
Dietary diversity score among children 6–23 months (mean (±SD))* 1.29 (±1.07) 1.21 (±1.07) t = 0.84, P = 0.401
Mean feeding frequency among children 6–23 months (mean (±SD))* 1.78 (±1.67) 1.73 (±1.60) t = 0.43, P = 0.662
♦n = 1,573 pairs of children.
*n = 898 pairs of children.
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plemented group, the risk of anemia was significantly
reduced, represented by a RR of 0.91 (95% CI: 0.86-0.96)
(Table 3).
Effect modification by household wealth status
The association between VAS and anemia was inde-
pendently computed across the three wealth strata
(poor, middle and rich). The analysis indicated that the
significant association was only restricted in the ‘poor’
household wealth stratum (RR = 0.74 (95% CI: 0.61-
0.90)). In contrast, the association was marginal in the
middle (P = 0.059) and insignificant in the rich wealth
strata (P = 0.630) (Table 4).
Likewise the mean hemoglobin differences between
matched supplemented and non-supplemented children
in the poor, middle and rich wealth categories were 5.4
(±26.8), 3.1 (±25.8) and 0.3 (±23.7) g/l, respectively.Table 2 Mean hemoglobin concentration in vitamin A
supplemented and non-supplemented children aged
6–59 months, Ethiopia 2010
Mean hemoglobin concentration (g/l) Mean (±SD)
All children (n = 4794) 106.7 (±21.1)
VA supplemented children (n = 2397) 107.5 (±17.9)
VA non-supplemented children (n = 2397) 106.0 (±23.8)
Paired mean difference (supplemented - non
supplemented) (n = 2397)
1.5 (±21.1)Pared t-test analysis was significant only in the poor
tertile (P = 0.000). Comparison of the three mean dif-
ferences using one way ANOVA showed statistically
significant global difference (P = 0.039) and Tukey’s post-
hoc test detected significant difference between poor and
rich tertiles (Table 5).
Evaluation of the practical significance of VAS in the
prevention of anemia
In the evaluation of the effect of an intervention on an
outcome, along with statistical level of significance, it’s
important to appraise its practical significance using
effect size estimates. This is particularly important in
studies involving large sample sizes as they are likely to
detect statistically significant difference even in the pres-
ence of trivial treatment effect.
In the current study, the effect sizes computed based
on standardized mean differences (Cohen’s d) amongTable 3 Pattern of anemia among 2397 paired vitamin A
supplemented and non-supplemented children aged
6–59 months, Ethiopia, 2010
Supplemented Total
Normal Anemic
Non-supplemented Normal 558 541 1099
Anemic 653 645 1298
Total 1211 1186 2397
Matched RR = 0.91 (95% CI: 0.86-0.96).
McNemar’s χ2 = 10.51, P = 0.001.
Table 4 The association between VAS and anemia among children aged 6–59 months across three household wealth
strata, Ethiopia, 2010
Wealth tertiles Number of matched children♦ RR (95% CI) in VA supplemented group McNemar’s χ2 test
Poor 331 0.74 (0.61-0.90)* χ2 = 9.48, P = 0.002*
Middle 311 0.86 (0.74-1.00) χ2 = 3.55, P = 0.059
Rich 329 0.96 (0.82-1.12) χ2 = 0.32, P = 0.630
♦Number of matched children both selected from the respective wealth category.
*Statistically significant.
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0.07 and 0.20, respectively. As compared to the cutoff
points recommended by J Cohen [30], the effect size
estimates were modest.
Discussion
In the current study a relatively small but statistically sig-
nificant hemoglobin increase of 1.5 g/l was observed in VA
supplemented group. The increment is minimal as com-
pared to results from three previous RCTs that had used
daily or weekly VAS. The RCTs conducted in Tanzania
(1.5 mg VA for 3 days a week for 3 months) [8], Belize
(1.0 mg per week for 6 months) [9] and Guatemala (3.0 mg
VA daily for 2 months) [10] reported statistically significant
9.9, 8.0 and 6.1 and g/l hemoglobin increments in VA sup-
plemented children, respectively. Compared to the effects
reported from these RCTs, the small treatment effect esti-
mated from the current study might be due to variation
in type of VAS regimen (i.e. daily, weekly or semi-annual
supplementation). Though no study so far compared the
effectiveness of various VAS regimens, few studies on other
micronutrients documented better physiological responses
in more frequent supplementation regimens [31-33].
Clinical trials based on high dose VA supplementation
in children have generated mixed findings with respect
to the impact on hemoglobin. In Peru [15] and Thailand
[16] 30 mg and 60 mg VAS respectively, did not yield
significant hemoglobin improvements. Another study in
Thailand [13] witnessed a significant but relatively slim
3 g/l increment following administration of single 60 mg
VA supplement. In Indonesia, 60 mg VAS did not show
significant effect among clinically normal children but
significantly increased the hemoglobin concentration
by 7 g/l among anemic children [14]. In Morocco, two
60 mg VA supplementations given 5 months apartTable 5 Mean hemoglobin difference between matched vitam
6–59 months across three household wealth strata, Ethiopia,






**Used as a measure of heterogeneity of effects.increased hemoglobin by 6 g/l [7]. The findings of the
current study along with the aforementioned trials may
indicate that high dose VAS has less remarkable effect on
blood hemoglobin level than daily or weekly regimens.
In the current study, the relatively weak association
observed between VAS and hemoglobin/anemia can also
be due to sub-optimal dietary iron intake of the study sub-
jects. As VA is assumed to increase hemoglobin level prin-
cipally through facilitating hematopoisis and mobilization
of iron store [5,6], VAS in the absence of optimal iron sta-
tus might not illustrate pronounced effect on hemoglobin
concentration. According to EDHS 2011, among children
aged 6–23 months only 13.3% consumed iron rich foods
in the preceding day of the survey and among children
6–59 months only 6.0% had any form of iron supple-
mentation in the previous one week of the survey [3].
The stratified analysis based on household wealth sta-
tus indicated that the significant association between
VAS and anemia was only restricted to children from
the poor households. The strength of association between
the two variables uniformly reduced across the three
wealth strata — poor (RR = 0.74), middle (RR = 0.86)
and rich (RR = 0.96). This might be due to the reason
that children from the poor families would have less
access to VA rich foods hence they tend to benefit more
from the supplementation. Conversely among children
from households of higher socio-economic means, the
protective effect of VAS would be minimal as they may
already been adequate in the baseline VA status. So far
no trial examined the modifying effects of household
economic status on responses to micronutrient supple-
mentation among children. But a study among pregnant
women in China reported that in women from the poor-
est tertile of the socio-economic status, micronutrient
supplementation significantly reduced risk of lowin A supplemented and non-supplemented children aged
2010
) Paired t statistic and p value One Way ANOVA**
t = 3.64, P = 0.000* F = 3.24, P = 0.039*
t = 1.66, P = 0.979
t = 0.26, P = 0.796
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similar effects had not been seen among women from
the wealthier households [34].
In Ethiopia, VAS is usually given to children along with
other services like vaccination and mass-deworming. These
services can also have independent positive effect on
hemoglobin and could potentially confound the associ-
ation between VAS and anemia. However, in the current
study the confounding effect might not be a serious con-
cern as both of the variables had been used to generate
the propensity score for matching.
Some limitations need to be considered while inter-
preting the findings of the study. Primarily the ascertain-
ment of the VAS status was entirely based on mothers’
recall. This makes the study liable to recall and mis-
classification bias and it can result in under- or over-
estimation the actual strength of association. Though
the study used propensity score matching to balance VA
supplemented and non-supplemented groups based on
selected covariates, still confounding can happen due to
lack of comparability in other unmeasured characteristics.
Further, presumably there is some delay between VAS and
its effect on hemoglobin. However, in the current study
the association was measured regardless of the time gap
between the supplementation and hemoglobin determin-
ation, consequently this can result in under estimation of
the association. The large number of subjects excluded
from the study due to lack of appropriate matches can also
be considered as a drawback of the propensity score
matching method. In general, as the study is observational,
the strength of the evidence might not be up to the level
of RCTs.Conclusion
Single high dose VAS among Ethiopian children 6–
59 months of age was associated with a modest in-
crease in hemoglobin and decrease in risk of anemia.
Household wealth status may modify the apparent as-
sociation between VAS and hemoglobin status.
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